XML 86 R77.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity (Details) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Feb. 02, 2024
Jan. 15, 2024
Dec. 06, 2023
Sep. 15, 2022
Jan. 04, 2022
Mar. 31, 2018
Feb. 29, 2024
Feb. 28, 2023
Feb. 29, 2024
Feb. 28, 2023
May 31, 2022
Nov. 28, 2023
Nov. 27, 2023
May 31, 2023
Sep. 14, 2022
Stockholders' Equity (Details) [Line Items]                              
Common Stock, Shares Authorized             345,000,000   345,000,000     350,000,000 187,500,000 187,500,000  
Common Stock, Par or Stated Value Per Share (in Dollars per share)             $ 0.0001   $ 0.0001         $ 0.0001  
Preferred Stock, Shares Authorized             5,000,000   5,000,000         5,000,000  
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)             $ 0.001   $ 0.001         $ 0.001  
Stockholders' Equity, Reverse Stock Split       1-for-4                      
Common Stock, Shares, Outstanding       72,517,570     137,675,276   137,675,276         72,543,141 290,070,272
Stock Issued During Period, Shares, Reverse Stock Splits       217,552,702                      
Stock Issued During Period, Shares, Stock Splits       576                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)     $ 0.0345   $ 1.65                    
Debt Conversion, Original Debt, Amount (in Dollars)                 $ 0 $ 11,532,680          
Litigation Settlement, Expense (in Dollars)                   $ 1,250,000          
Share Return                   13,174,402          
Number of Warrants Cancelled                   454,548          
Class of Warrant or Rights, Granted         757,576 51,310     0   20,232,775        
Gain (Loss) on Extinguishment of Debt (in Dollars)             $ (3,404,910) $ 0 $ (3,404,910) $ (6,659,359)          
Debt Instrument, Issued, Principal (in Dollars)         $ 2,500,000                    
Warrants and Rights Outstanding, Term         3 years                    
Debt Instrument, Face Amount (in Dollars)       $ 18,846,721                      
Debt Instrument, Convertible, Conversion Price (in Dollars per share)       $ 0.4                     $ 1.2
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       6,801,298                     3,400,652
Warrant Description       each warrants issuable pursuant to the conversion of such debentures is exercisable for one share of the Company’s common stock at a price of $0.40 per share                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross                 8,250,000            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)                 $ 0.039            
Share-Based Payment Arrangement, Expense (in Dollars)                   0          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)             $ 3,678 $ 0 $ 3,678 $ 0          
Share Price (in Dollars per share)             $ 0.0495   $ 0.0495            
To Be Issued to Officers [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)           $ 5                  
WestPark Capital Inc [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Unit, Description           Each unit consists of four shares of common stock and one warrant to purchase a share of common stock for $3.00.                  
Four Convertible Notes Payable [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Converted Instrument, Shares Issued   32,132,135 32,000,000                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)   $ 0.0333                          
Four Convertible Notes Payable [Member] | Principal [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)   $ 1,070,000 $ 960,000                        
Four Convertible Notes Payable [Member] | Accrued Interest [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)     $ 144,000                        
Canaccord Debentures [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Converted Instrument, Shares Issued       28,414,149                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)       $ 0.4                      
Debt Conversion, Original Debt, Amount (in Dollars)       $ 8,098,033                      
Class of Warrant or Rights, Granted       14,207,075                      
Gain (Loss) on Extinguishment of Debt (in Dollars)       $ 4,547,660                      
Canaccord Debentures [Member] | Principal [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)       7,965,278                      
Canaccord Debentures [Member] | Accrued Interest [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)       $ 132,755                      
U.S. Convertible Debentures [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Converted Instrument, Shares Issued       12,051,397                      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)       $ 0.4                      
Debt Conversion, Original Debt, Amount (in Dollars)       $ 3,434,647                      
Class of Warrant or Rights, Granted       6,025,700                      
Gain (Loss) on Extinguishment of Debt (in Dollars)       $ 2,111,699                      
U.S. Convertible Debentures [Member] | Principal [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)       3,378,342                      
U.S. Convertible Debentures [Member] | Accrued Interest [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Debt Conversion, Original Debt, Amount (in Dollars)       $ 56,305                      
Board of Directors Chairman [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture   1,000,000                          
Shares Issued, Price Per Share (in Dollars per share)   $ 0.0388                          
Share-Based Payment Arrangement, Option [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Payment Arrangement, Expense (in Dollars)                 $ 6,439            
Chief Executive Officer [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 6,000,000                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.039                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 36 months                            
Vice President [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 750,000                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.039                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 36 months                            
Chief Accounting Officer [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 750,000                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.039                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 36 months                            
Chief Operating Officer [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 500,000                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.039                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 24 months                            
Chief Scientific Officer [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 250,000                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.039                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 months                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 24 years